NAUT · 10-Q · 2026Q1 · Full report
Interest Income and Investment Yield
Nautilus Biotechnology, Inc. · 2026-04-28 · Importance 40 · Surprise 56
Interest income fell to $1.4 million in Q1 2026 from $2.2 million in Q1 2025, a decline of $0.8 million, or 35%. Management attributes the decrease to a lower balance of cash, cash equivalents and investments and to decreased yield rates on investments during the period. Other income (net interest and miscellaneous items) declined by $0.8 million, or 36%, year over year. The decline in interest income reduces non-operating income available to offset operating losses.
Key facts
- Interest income was $1,442,000 for the three months ended March 31, 2026, compared to $2,231,000 for the three months ended March 31, 2025, a decrease of $789,000 or 35%.
- Total other income was $1,427,000 for the three months ended March 31, 2026, compared to $2,231,000 for the three months ended March 31, 2025, a decrease of $804,000 or 36%.
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| net_income | negative | realized | — | Total other income was $1,427,000 for the three months ended March 31, 2026, compared to $2,231,000 for the three months ended March 31,… |